BioSpace News Archive

Kaleido Biosciences, Inc., a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health announced the initiation of a controlled clinical study evaluating Microbiome Metabolic Therapy candidate KB109 added to Supportive Self-Care for outpatients who are positive for SARs-Cov-2 infection with mild-to-moderate COVID-19.

Positive Phase 1 cosmetic clinical study results of BX001 in acne-prone skin reported; planned advance to Phase 2 study with readout expected in the second quarter of 2021

Initiating Clinical Studies of KB109 in Outpatients with Mild-to-Moderate COVID-19; Data Anticipated in Q4 2020

Merck, known as MSD outside the United States and Canada, announced that Mike Nally, executive vice president and chief marketing officer, is scheduled to participate in a fireside chat at the UBS Virtual Global Healthcare Conference on May 18, 2020, at 11:40 a.m. EDT.

“The incredible support from Lockheed Martin is a lifeline to our patients” - NMDP/Be The Match Chief Policy Officer Brian Lindberg

Exicure, Inc., the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid technology, reported financial results for the quarter ended March 31, 2020 and provided an update on corporate progress.

3M reported sales information for the month of April 2020. The company withdrew its full-year 2020 outlook on April 28, 2020, due to the uncertain impact of the COVID-19 pandemic, and committed to provide monthly updates until it is better able to forecast future performance.

Iterum Therapeutics plc, a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, reported financial results for the first quarter ended March 31, 2020.

Combines market leaders in wound care clinical documentation, wound imaging and predictive analytics

On 27 May, Lonza will host a free 60-minute webinar on best practices for pharmaceutical manufacturers moving from a paper-based to a paperless record management approach to improve their processes and maximize productivity.